Seagen Inc logo

Seagen Inc

4
NAS:SGEN (USA)   Ordinary Shares
$ 212.20 -0.04 (-0.02%) 10:27 AM EST
P/E:
At Loss
P/B:
15.20
Market Cap:
$ 39.83B
Enterprise V:
$ 38.64B
Volume:
216.66K
Avg Vol (2M):
1.32M
Also Trade In:
Volume:
216.66K
Market Cap $:
39.83B
PE Ratio:
At Loss
Avg Vol (2M):
1.32M
Enterprise Value $:
38.64B
PB Ratio:
15.20

Business Description

Description
Seagen (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer, Tukysa for breast cancer, and Tivdak for cervical cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.
Name Current Vs Industry Vs History
Cash-To-Debt 13.29
Equity-to-Asset 0.75
Debt-to-Equity 0.04
Debt-to-EBITDA -0.15
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 26.81
Distress
Grey
Safe
Beneish M-Score -2.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.01
9-Day RSI 60.33
14-Day RSI 62.49
6-1 Month Momentum % 1.6
12-1 Month Momentum % 49.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.3
Quick Ratio 2.66
Cash Ratio 1.69
Days Inventory 297.83
Days Sales Outstanding 84.7
Days Payable 105.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.7
Shareholder Yield % -0.04

Financials (Next Earnings Date:2023-10-27 Est.)

SGEN's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SGEN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Seagen Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2,162.001
EPS (TTM) ($) -3.89
Beta -0.04
Volatility % 37.07
14-Day RSI 62.49
14-Day ATR ($) 2.267107
20-Day SMA ($) 208.689
12-1 Month Momentum % 49.77
52-Week Range ($) 116.08 - 217.08
Shares Outstanding (Mil) 187.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Seagen Inc Filings

Filing Date Document Date Form
No Filing Data

Seagen Inc Stock Events

Event Date Price($)
No Event Data

Seagen Inc Frequently Asked Questions

What is Seagen Inc(SGEN)'s stock price today?
The current price of SGEN is $212.20. The 52 week high of SGEN is $217.08 and 52 week low is $116.08.
When is next earnings date of Seagen Inc(SGEN)?
The next earnings date of Seagen Inc(SGEN) is 2023-10-27 Est..
Does Seagen Inc(SGEN) pay dividends? If so, how much?
Seagen Inc(SGEN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1